Blood Screening Test for Alzheimer’s disease


Development of a diagnostic screening test for the detection and differentiation of Alzheimer's disease in humans. 


Development of an enrichment process for diagnostically relevant tau protein in blood samples from patients.


Improvement of the detection limit of immunological test methods for Alzheimer's related biomarkers. 

Joint Project

Roboscreen GmbH, Paul-Flechsig-Institute and Leipzig Medical Biobank (LIFE) of Leipzig University develop and evaluate enrichment methods as well as improvement of biomarker detection and quantification of Alzheimer's related biomarkers in blood/serum/plasma and urine.

Funded Project (100550551)

Supported by funding from the European Union and the Free State of Saxony from ERDF funds.


Started in December 2021.